855 related articles for article (PubMed ID: 25403813)
21. A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder.
Simpson HB; Foa EB; Liebowitz MR; Ledley DR; Huppert JD; Cahill S; Vermes D; Schmidt AB; Hembree E; Franklin M; Campeas R; Hahn CG; Petkova E
Am J Psychiatry; 2008 May; 165(5):621-30. PubMed ID: 18316422
[TBL] [Abstract][Full Text] [Related]
22. Predictors associated with improved cognitive-behavioral therapy outcome in pediatric obsessive-compulsive disorder.
Torp NC; Dahl K; Skarphedinsson G; Compton S; Thomsen PH; Weidle B; Hybel K; Valderhaug R; Melin K; Nissen JB; Ivarsson T
J Am Acad Child Adolesc Psychiatry; 2015 Mar; 54(3):200-207.e1. PubMed ID: 25721185
[TBL] [Abstract][Full Text] [Related]
23. [Mindfulness-based interventions in obsessive-compulsive disorder: Mechanisms of action and presentation of a pilot study].
Gasnier M; Pelissolo A; Bondolfi G; Pelissolo S; Tomba M; Mallet L; N'diaye K
Encephale; 2017 Dec; 43(6):594-599. PubMed ID: 27887679
[TBL] [Abstract][Full Text] [Related]
24. Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial.
Pediatric OCD Treatment Study (POTS) Team
JAMA; 2004 Oct; 292(16):1969-76. PubMed ID: 15507582
[TBL] [Abstract][Full Text] [Related]
25. Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive-compulsive disorder: the Pediatric OCD Treatment Study II (POTS II) randomized controlled trial.
Franklin ME; Sapyta J; Freeman JB; Khanna M; Compton S; Almirall D; Moore P; Choate-Summers M; Garcia A; Edson AL; Foa EB; March JS
JAMA; 2011 Sep; 306(11):1224-32. PubMed ID: 21934055
[TBL] [Abstract][Full Text] [Related]
26. Optimal treatment for obsessive compulsive disorder: a randomized controlled feasibility study of the clinical-effectiveness and cost-effectiveness of cognitive-behavioural therapy, selective serotonin reuptake inhibitors and their combination in the management of obsessive compulsive disorder.
Fineberg NA; Baldwin DS; Drummond LM; Wyatt S; Hanson J; Gopi S; Kaur S; Reid J; Marwah V; Sachdev RA; Pampaloni I; Shahper S; Varlakova Y; Mpavaenda D; Manson C; O'Leary C; Irvine K; Monji-Patel D; Shodunke A; Dyer T; Dymond A; Barton G; Wellsted D
Int Clin Psychopharmacol; 2018 Nov; 33(6):334-348. PubMed ID: 30113928
[TBL] [Abstract][Full Text] [Related]
27. Effect of Internet-Based vs Face-to-Face Cognitive Behavioral Therapy for Adults With Obsessive-Compulsive Disorder: A Randomized Clinical Trial.
Lundström L; Flygare O; Andersson E; Enander J; Bottai M; Ivanov VZ; Boberg J; Pascal D; Mataix-Cols D; Rück C
JAMA Netw Open; 2022 Mar; 5(3):e221967. PubMed ID: 35285923
[TBL] [Abstract][Full Text] [Related]
28. Mindfulness-based Cognitive Therapy for Obsessive-Compulsive Disorder: A Pilot Study.
Didonna F; Lanfredi M; Xodo E; Ferrari C; Rossi R; Pedrini L
J Psychiatr Pract; 2019 Mar; 25(2):156-170. PubMed ID: 30849066
[TBL] [Abstract][Full Text] [Related]
29. Transcutaneous electrical acupoint stimulation as an adjunct therapy for obsessive-compulsive disorder: A randomized controlled study.
Feng B; Zhang ZJ; Zhu RM; Yuan GZ; Luo LY; McAlonan GM; Xu FZ; Chen J; Liu LY; Lv YY; Wong HK; Zhang Y; Zhu LX
J Psychiatr Res; 2016 Sep; 80():30-37. PubMed ID: 27281260
[TBL] [Abstract][Full Text] [Related]
30. What Is the Added Benefit of Combining Cognitive Behavioral Therapy and Selective Serotonin Reuptake Inhibitors in Youth with Obsessive Compulsive Disorder? A Bayesian Hierarchical Modeling Meta-Analysis.
Mendez EM; Dahlsgaard KK; Hjelmgren JM; Mills JA; Suresh V; Strawn JR
J Child Adolesc Psychopharmacol; 2023 Aug; 33(6):203-211. PubMed ID: 37347947
[No Abstract] [Full Text] [Related]
31. Metacognitive Training for Obsessive-Compulsive Disorder: a study protocol for a randomized controlled trial.
Miegel F; Demiralay C; Moritz S; Wirtz J; Hottenrott B; Jelinek L
BMC Psychiatry; 2020 Jul; 20(1):350. PubMed ID: 32631261
[TBL] [Abstract][Full Text] [Related]
32. Randomized trial of the efficacy of trial-based cognitive therapy for obsessive-compulsive disorder: preliminary findings.
Rodrigues EP; Fechine AJB; Oliveira AC; Matos CFF; Passarela CM; Hemanny C; Dias FM; Batista JW; Albuquerque LCN; Soares MS; Coelho PE; Araújo VPC; Ayres ZM; de Oliveira IR
Trends Psychiatry Psychother; 2023; 45():e20210247. PubMed ID: 35500249
[TBL] [Abstract][Full Text] [Related]
33. Cognitive behavior therapy in medication non-responders with obsessive-compulsive disorder: a prospective 1-year follow-up study.
Anand N; Sudhir PM; Math SB; Thennarasu K; Janardhan Reddy YC
J Anxiety Disord; 2011 Oct; 25(7):939-45. PubMed ID: 21689902
[TBL] [Abstract][Full Text] [Related]
34. Distinct trajectories of long-term symptom severity in pediatric obsessive-compulsive disorder during and after stepped-care treatment.
Jensen S; Højgaard DRMA; Hybel KA; Mortensen EL; Skarphedinsson G; Melin K; Ivarsson T; Nissen JB; Weidle B; Valderhaug R; Torp NC; Dahl K; Compton S; Thomsen PH
J Child Psychol Psychiatry; 2020 Sep; 61(9):969-978. PubMed ID: 31736082
[TBL] [Abstract][Full Text] [Related]
35. Metacognitive therapy versus exposure and response prevention for obsessive-compulsive disorder: study protocol for a randomized controlled trial.
Melchior K; Franken I; Deen M; van der Heiden C
Trials; 2019 May; 20(1):277. PubMed ID: 31109349
[TBL] [Abstract][Full Text] [Related]
36. Predictors and moderators of treatment outcome in the Pediatric Obsessive Compulsive Treatment Study (POTS I).
Garcia AM; Sapyta JJ; Moore PS; Freeman JB; Franklin ME; March JS; Foa EB
J Am Acad Child Adolesc Psychiatry; 2010 Oct; 49(10):1024-33; quiz 1086. PubMed ID: 20855047
[TBL] [Abstract][Full Text] [Related]
37. Addition of cognitive-behavioral therapy for nonresponders to medication for obsessive-compulsive disorder: a naturalistic study.
Tundo A; Salvati L; Busto G; Di Spigno D; Falcini R
J Clin Psychiatry; 2007 Oct; 68(10):1552-6. PubMed ID: 17960971
[TBL] [Abstract][Full Text] [Related]
38. Cognitive-behaviour therapy and medication in the treatment of obsessive-compulsive disorder: a controlled study.
O'Connor K; Todorov C; Robillard S; Borgeat F; Brault M
Can J Psychiatry; 1999 Feb; 44(1):64-71. PubMed ID: 10076743
[TBL] [Abstract][Full Text] [Related]
39. Internet-Based Cognitive Behavioral Therapy With Real-Time Therapist Support via Videoconference for Patients With Obsessive-Compulsive Disorder, Panic Disorder, and Social Anxiety Disorder: Pilot Single-Arm Trial.
Matsumoto K; Sutoh C; Asano K; Seki Y; Urao Y; Yokoo M; Takanashi R; Yoshida T; Tanaka M; Noguchi R; Nagata S; Oshiro K; Numata N; Hirose M; Yoshimura K; Nagai K; Sato Y; Kishimoto T; Nakagawa A; Shimizu E
J Med Internet Res; 2018 Dec; 20(12):e12091. PubMed ID: 30559094
[TBL] [Abstract][Full Text] [Related]
40. Effect of an Internet-Delivered Stepped-Care Program vs In-Person Cognitive Behavioral Therapy on Obsessive-Compulsive Disorder Symptoms in Children and Adolescents: A Randomized Clinical Trial.
Aspvall K; Andersson E; Melin K; Norlin L; Eriksson V; Vigerland S; Jolstedt M; Silverberg-Mörse M; Wallin L; Sampaio F; Feldman I; Bottai M; Lenhard F; Mataix-Cols D; Serlachius E
JAMA; 2021 May; 325(18):1863-1873. PubMed ID: 33974020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
